Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for MRNA, sign up here.
Income Statement
Revenue
$6.8bn
Gross Profit
$2.2bn
Earning before Tax
$-3.9bn
Net Income
$-4.7bn
Net Income Common Shareholders
$-4.7bn
EPS
-12.33
Balance Sheet
Cash
$2.9bn
Debt
$1.2bn
Assets
$18.4bn
Liabilities
$4.6bn
Equity
$13.9bn
Enterprise Value
$36.3bn
Cash Flow Statement
Net Cash from Operations
$-3.1bn
Net Cash from Investing
$4.2bn
Net Cash from Financing
$-1.4bn
Net Cash Flow
$-0.3bn
Free Cash Flow
$-3.8bn
Free Cash Flow per Share
$-0.0m
Metrics
Price to Equity
-8.04
Price to Equity (Damodaran)
-8.07
Price to Book
2.74
Net Margin
-0.69
Return on Equity
-0.30
Return on Sales
-0.58
Get immediate access to 5-years of reference grade data for MRNA for free.
Sign upModerna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a strategic partnership with Caris Life Sciences to advance mRNA-Based oncology therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Company Info
Industry
Biotechnology
Employees
3,900
Address
200 Technology Square
Cambridge, MA 02139
United States
Phone
617 714 6500
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.